“Lynparza, Best-in-Class as well as First-in-Class"
[Medical Team’s Medicine Story] ④ Astrazeneca Korea Medical Team, Joohwan Lee
Astrazeneca Korea Medical Team, Joohwan Lee. [MedigateNews] The BRCA gene repairs damaged DNA, preventing normal cells from developing into tumors. BRCA mutations affect the development of breast cancer, ovarian cancer, pancreatic cancer, and prostate cancer. Angelina Jolie, who has a family history of breast cancer and ovarian cancer, underwent a preventive operation in breast and ovary in 2013 and 2015 respectively, after discovering that the BRCA1 gene had a mutation in the BRCA test. Linparz메디게이트뉴스 l 2020.06.17 17:38
"Biktarvy, the best of the best HIV medicine that has been developed by Gilead Sciences"
[Medical Team’s Medicine Story] ③ Gilead Science Korea Medical Team, Jung Ah Lee
Gilead Science Korea Medical Team, Jung Ah Lee. [MedigateNews] The HIV, previously called incurable disease, has become a disease that can be managed like a chronic disease if medication is continuously taken. The current treatment trend globally is to recommend the initiation of treatment as early as possible in the early stages of HIV infection and the use of second-generation Integrase Strand Transfer Inhibitor (InSTI) as antiretroviral therapy. Gilead Sciences launched ‘Truvada’ that is appr메디게이트뉴스 l 2020.06.17 17:38
"With Alprolix, we will open up new changes to the patients with hemophilia B"
[Drug story of a medical team]② Hyosun Shin, Director at Sanofi Genzyme
Hyosun Shin, Director of Rare Blood Disease Division at Sanofi Genzyme [MedigateNews] Hemophilia is a congenital blood clotting disease in which hemostasis is delayed due to the absence or lack of some of the blood coagulation factors involved in hemostasis. The main clinical feature is joint bleeding. If the joint bleeding is repeated, the joint is damaged and cartilage is eroded, leading to complications called hemophilic arthrosis in the long term. In addition, if bleeding suddenly occurs in메디게이트뉴스 l 2020.05.25 12:27
Adcetris presents new paradigm for cutaneous cell lymphoma treatment with ADC technology
[Drug story of a medical team]① Yeaji Kim, MSL of Takeda Pharmaceutical Korea
Yeaji Kim, MSL of Medical Division, Takeda Pharmaceutical Korea. [MedigateNews] Lymphoma is rare in kind, but it is a disease in which treatment results drop rapidly when relapsing, and is largely divided into Hodgkin lymphoma and non-Hodgkin lymphoma. 5% of all lymphomas are Hodgkin's lymphomas and the rest are non-Hodgkin's lymphomas. Adcetris(Brentuximab vedotin), a drug for the treatment of lymphoma of Takeda Pharmaceutical Company, has six indications for each subtype of Hodgkin's lymphoma메디게이트뉴스 l 2020.05.25 12:20
The reason why Korean investors paid attention to 'Hummingbird Bioscience'
Dr. Piers Ingram, CEO and co-founder of Hummingbird Bioscience Piers Ingram CEO "Development of innovative targeted therapeutics with a system biology-based approach and technology platform" [관련기사=SK 등 한국 투자자들이 싱가포르 바이오벤처 '허밍버드 바이오사이언스'에 주목한 이유는] Singapore bio-venture company Hummingbird Bioscience received an additional investment of approximately 8 billion won(about 6.5 million USD) in May of this year following the attraction of Series B investment of 27.2 billion won(19 million USD) last Dec박도영 l 2020.05.21 14:45
‘Genome, the Future Medicine that has Approached’ is published as a revised edition
Contents on diagnostic methods of COVID-19, cancer immunotherapy, DTC
‘Genome, the Future Medicine that has Approached’ is published as a revised edition to celebrate the selection by Sejong Books Written by Dr. Kyung-Cheol Kim, published by MEDI:GATE NEWS... Contents on diagnostic methods of COVID-19, cancer immunotherapy, DTC and the latest trends included [관련기사='유전체, 다가온 미래의학' 세종도서 선정 기념 개정증보판 출간] On the 21st, a revised version of “Genome, the Future Medicine that has Approached” was published and this is based on the column entitled “The special lecture for th메디게이트뉴스 l 2020.05.02 13:30
Timing for end point of COVID 19… 8 out of 10 medical doctors predict “after year-end or endemic”
Changes in medical environment are wearing of masks (68%) and decrease of patients with cold (50%), concern on financial and employment difficulties (97.4%) [관련기사=코로나19 종식 시점 언제쯤...의사 10명 중 8명 "올해 연말 이후나 토착화 예상, 사회적 거리두기 기간 연장 필요"] Eight out of ten South Korean medical doctors predict that the outbreak of COVID-19 will continue until year-end through next year, or become endemic without an end. MEDI:GATE NEWS, a medical journal, released the results of a survey on COVID-19 conducted for 1,520메디게이트뉴스 l 2020.05.02 13:27
South Korean Doctors said, "I'm tired now. Please stop all foreigners from entering the country."
GettyImageBank [관련기사=정부의 초기 방역실패, 의료진과 공무원들의 희생으로 간신히 버텨...이제라도 입국 금지 시행하라] Kim Jae-yeon, Lawmaker of the Korean Society of Obstetrics and Gynecology, director of social policy in North Jeolla Province Paik Kyung-ran, chairman of the Korea Society for Influenza, said on his Facebook page on Wednesday that he hopes foreigners will be banned from entering the country at least now. Baek said, 'A foreigner was hospitalized and bought an interpreter at the nurses' request. Please stop foreigners. I'm메디게이트뉴스 l 2020.03.30 11:08
"Design a clinical trial with the intention of getting FDA approval from the early stage"
GettyImageBank [관련기사="글로벌 신약개발시 美FDA 승인을 받겠다는 생각으로 임상시험 설계하라"] When developing a new drug, after deciding on entry indications, it is necessary to draw the big picture of the most successful clinical development at the fastest rate and design the initial clinical research, and then the close communication with the regulatory agency from the early stage will increase the success rate of development. Moon Hanlim, CEO of CUREnCARE Research, shared the approval know-how of the U.S. Food and Drug Adm메디게이트뉴스 l 2020.01.06 16:53
DTC genetic tests for 4 companies expanded up to 56 items
GettyImageBank [관련기사=랩지노믹스·마크로젠·EDGC·테라젠이텍스 DTC 유전자검사 최대 56항목까지 늘었다] Direct To Consumer(DTC) genetic testing, which was available only for 12 items and 46 genes such as blood sugar, blood pressure, hair loss, and vitamin C, will be permitted without restrictions up to 56 items (wellness) in the areas of kinetic compatibility, alcohol flush, and genealogy searches for the next 2 years. However, the target institutions are only 4 companies that have received quality control certification from the메디게이트뉴스 l 2020.01.06 16:52